Name: | Description: | Size: | Format: | |
---|---|---|---|---|
322.86 KB | Adobe PDF |
Advisor(s)
Abstract(s)
The effect of estradiol-17b (E2) implants on the in vitro secretion of prolactin (PRL) and its modulation by vasoactive intestinal
peptide (VIP) in a marine teleost, sea bream (Sparus aurata L.), was determined. Experiments were conducted during winter and
spring. During winter, fish (n¼130, body weight 50–70 g) were randomly divided into 2 groups; control and E2 treated (10 mg/kg,
wet weight). Fish were sacrificed after 7 days treatment and in vitro pituitary cultures in Ringer bicarbonate supplemented with
increasing doses (0–200 nM) of VIP were carried out for 18 h. Culture medium was analysed by PAGE and secreted PRL quantified
by densitometry. Fish treated with E2 secreted significantly more PRL ðP < 0:05Þ in vitro than control fish. In E2 primed fish VIP
caused a dose-dependent inhibition of PRL secretion in vitro. VIP had no detectable effect on the secretion of PRL from control
pituitaries. Treatment with E2 had a different effect during spring; PRL secretion was significantly decreased ðP < 0:01Þ compared
with the control fish. Anatomical evidence of abundant VIPimmunoreactive nerve fibres in neurohypophysial (NH) tissue penetrating
the rostral pars distalis provide further evidence supporting an action for VIPin the regulation of PRL cells. In conclusion,
the responsiveness of PRL in the pituitary gland varied with season. Moreover, in the sea bream VIP appears to modulate PRL
secretion from E2 primed pituitary glands.
Description
Keywords
Estrogen Prolactin Regulation Season Vasoactive intestinal peptide Teleost fish
Citation
Lilia Brinca, Juan Fuentes, and D.M. Power, "The regulatory action of estrogen and vasoactive intestinal peptide on prolactin secretion in sea bream (Sparus aurata, L.)" in General and Comparative Endocrinology 131 (2003) 117–125.
Publisher
Elsevier